Shanghai Kehua Bio-Engineering Co.,Ltd researches and develops, produces, and sells in vitro diagnostic reagents, medical testing equipment and other products in China and internationally. It offers signature products, including immunoassay & clinical chemistry systems, HIV colloid gold test kits, ELISA HBV test kits, renal disease management, and automated comprehensive solutions for nucleic acid blood screening; automatic modular and clinical chemistry analyzer; automatic chemiluminescence immunoassay analyzers; and CLIA reagents tests. The company also provides automatic microplate reader, microplate washer, and enzyme-linked immunoassay reagents; diagnostic kit for HIV and SARS-CoV-2 IgM/IgG antibody; and fully automated nucleic acid blood screening laboratory and molecular diagnostics solutions. It serves hospitals, disease control and prevention centers, blood centers, bio-pharmaceutical enterprises, and scientific research institutions. The company also exports its products. Shanghai Kehua Bio-Engineering Co.,Ltd was founded in 1981 and is headquartered in Shanghai, the People's Republic of China.
Metrics to compare | 002022 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002022PeersSector | |
---|---|---|---|---|
P/E Ratio | −8.2x | −8.7x | −0.5x | |
PEG Ratio | 0.20 | 0.35 | 0.00 | |
Price/Book | 0.7x | 5.8x | 2.6x | |
Price / LTM Sales | 1.5x | 10.4x | 2.9x | |
Upside (Analyst Target) | - | 36.5% | 58.9% | |
Fair Value Upside | Unlock | −2.8% | 8.0% | Unlock |